These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2037141)

  • 1. Autoantibody-facilitated proteolytic cleavage: a new pathogenic mechanism in autoimmunity.
    Jackson J
    Biochem Soc Trans; 1991 Feb; 19(1):176-80. PubMed ID: 2037141
    [No Abstract]   [Full Text] [Related]  

  • 2. Autoantibody facilitated cleavage of C1-inhibitor in autoimmune angioedema.
    Jackson J; Sim RB; Whaley K; Feighery C
    J Clin Invest; 1989 Feb; 83(2):698-707. PubMed ID: 2536404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urticaria, angioedema, and autoimmunity.
    Zuraw BL
    Clin Lab Med; 1997 Sep; 17(3):559-69. PubMed ID: 9316773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hereditary angioedema and autoimmunity.
    Triggianese P; Guarino MD; Ballanti E; Chimenti MS; Perricone R
    Isr Med Assoc J; 2014 Oct; 16(10):622-4. PubMed ID: 25438448
    [No Abstract]   [Full Text] [Related]  

  • 5. The acquired C1-INH deficiencies with autoantibodies (AAE type II).
    Alsenz J; Loos M
    Behring Inst Mitt; 1989 Jul; (84):165-72. PubMed ID: 2679532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active disassembly of the first complement component, C-1, by C-1 inactivator.
    Ziccardi RJ; Cooper NR
    J Immunol; 1979 Aug; 123(2):788-92. PubMed ID: 110880
    [No Abstract]   [Full Text] [Related]  

  • 7. Polyclonal autoantibodies against C1 inhibitor in a case of acquired angioedema.
    Ponce IM; Caballero T; Reche M; Piteiro AB; López-Serrano MC; Fontán G; López-Trascasa M
    Ann Allergy Asthma Immunol; 2002 Jun; 88(6):632-7. PubMed ID: 12086372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acquired angioedema: observations on the mechanism of action of autoantibodies directed against C1 esterase inhibitor.
    Malbran A; Hammer CH; Frank MM; Fries LF
    J Allergy Clin Immunol; 1988 Jun; 81(6):1199-204. PubMed ID: 2454251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unmasking of acquired autoimmune C1-inhibitor deficiency by an angiotensin-converting enzyme inhibitor.
    Kleiner GI; Giclas P; Stadtmauer G; Cunningham-Rundles C
    Ann Allergy Asthma Immunol; 2001 Apr; 86(4):461-4. PubMed ID: 11345293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The classical complement pathway: activation and regulation of the first complement component.
    Cooper NR
    Adv Immunol; 1985; 37():151-216. PubMed ID: 3890478
    [No Abstract]   [Full Text] [Related]  

  • 11. Autoantibody-mediated acquired deficiency of C1 inhibitor.
    Jackson J; Feighery C
    N Engl J Med; 1988 Jan; 318(2):122-3. PubMed ID: 3336393
    [No Abstract]   [Full Text] [Related]  

  • 12. Acquired C1-inhibitor deficiency.
    Frank M
    Behring Inst Mitt; 1989 Jul; (84):161-4. PubMed ID: 2679531
    [No Abstract]   [Full Text] [Related]  

  • 13. C1 inhibitor-dependent dissociation of human complement component C1 bound to immune complexes.
    Sim RB; Arlaud GJ; Colomb MG
    Biochem J; 1979 Jun; 179(3):449-57. PubMed ID: 475762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of C1, C1-inactivator and C4 in modulating immune precipitation.
    Schifferli JA; Steiger G; Schapira M
    Clin Exp Immunol; 1985 Jun; 60(3):605-12. PubMed ID: 4017288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benefits of hydroxychloroquine in the treatment of a patient with angioedema due to acquired C1 inhibitor deficiency.
    Vincent D; Ponard D; Fiorella S; Drouet C
    Ann Allergy Asthma Immunol; 2015 Jan; 114(1):68-70. PubMed ID: 25457864
    [No Abstract]   [Full Text] [Related]  

  • 16. Mechanism of action of anti-C1-inhibitor autoantibodies: prevention of the formation of stable C1s-C1-inh complexes.
    He S; Sim RB; Whaley K
    Mol Med; 1998 Feb; 4(2):119-28. PubMed ID: 9508789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody-independent activation of C1. II. Evidence for two classes of nonimmune activators of the classical pathway of complement.
    Peitsch MC; Kovacsovics TJ; Tschopp J; Isliker H
    J Immunol; 1987 Mar; 138(6):1871-6. PubMed ID: 3029223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deficiency of serum C1 subcomponents and low functional activity of C1- inhibitor in a patient with urticaria and cryoglobulinemia.
    Lamas AM; Arnold PI; Schultz DR
    Am J Med; 1992 Apr; 92(4):445-6. PubMed ID: 1558093
    [No Abstract]   [Full Text] [Related]  

  • 19. C1 subcomponent complexes: basic and clinical aspects.
    Laurell AB; Sjöholm AG
    Behring Inst Mitt; 1993 Dec; (93):292-8. PubMed ID: 8172579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An IgG autoantibody which inactivates C1-inhibitor.
    Jackson J; Sim RB; Whelan A; Feighery C
    Nature; 1986 Oct 23-29; 323(6090):722-4. PubMed ID: 3534579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.